Intracoronary delivery of bone-marrow-derived stem cells

Stem Cell Research and Therapy

Volumn 1, Issue 4, 2010, Pages

  Bui, Quang T ^a   Gertz, Zachary M ^a   Wilensky, Robert L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; FIBRINOLYTIC AGENT; STROMAL CELL DERIVED FACTOR 1;

ACUTE HEART INFARCTION; BLOOD CLOT LYSIS; BONE MARROW CELL; CELL POPULATION; CELL SURVIVAL; CORONARY ARTERY BLOOD FLOW; CORONARY SINUS; ENDOTHELIAL PROGENITOR CELL; ENGRAFTMENT; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEMATOPOIETIC STEM CELL; HUMAN; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; INTRACORONARY DELIVERY; INTRACORONARY INFUSION; INTRAMYOCARDIAL DELIVERY; INTRAPERICARDIAL DELIVERY; INTRAVENOUS ADMINISTRATION; ISCHEMIC CARDIOMYOPATHY; ISCHEMIC HEART DISEASE; MESENCHYMAL STEM CELL; NONHUMAN; PERCUTANEOUS CORONARY INTERVENTION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RETROGRADE CORONARY SINUS DELIVERY; REVIEW; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STEM CELL TRANSPLANTATION;

BONE MARROW CELLS; CELL- AND TISSUE-BASED THERAPY; DRUG ADMINISTRATION ROUTES; HUMANS; MYOCARDIAL ISCHEMIA; MYOCARDIUM; MYOCYTES, CARDIAC; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 80052323427     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt29     Document Type: Review

References (48)

1. Heart disease and stroke statistics-2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, Haase N, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O'Donnell CJ, Roger V, Rumsfeld J, Sorlie P, Steinberger J, Thom T, Wasserthiel-Smoller S, Hong Y, American Heart Association Statistics Committee and Stroke Statistics Subcommittee, Circulation 2007 115 69 171 10.1161/CIRCULATIONAHA.106.179918 17194875 (Pubitemid 46226160)
2. Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. He J, Ogden LG, Bazzano LA, Vupputuri S, Loria C, Whelton PK, Arch Intern Med 2001 161 996 1002 10.1001/archinte.161.7.996 11295963 (Pubitemid 32295654)
3. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, Ford E, Furie K, Go A, Greenlund K, Haase N, Hailpern S, Ho M, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott M, Meigs J, Mozaffarian D, Nichol G, O'Donnell C, Roger V, Rosamond W, Sacco R, Sorlie P, Stafford R, Steinberger J, Thom T, Wasserthiel-Smoller S, Wong N, Wylie-Rosett J, Hong Y, American Heart Association Statistics Committee and Stroke Statistics Subcommittee, Circulation 2009 119 21 181 10.1161/CIRCULATIONAHA.108.191261 19075105
4. Adult bone marrow-derived cells for cardiac repair: a systemic review and meta-analysis. Abdel-Latif A, Bolli R, Tleyjeh IM, Montori VM, Perin EC, Hornung CA, Zuba-Surma EK, Al-Mallah M, Dawn B, Arch Intern Med 2007 167 989 997 10.1001/archinte.167.10.989 17533201 (Pubitemid 46835786)
5. Intracoronary infusion of autologous bone marrow cells and left ventricular function after acute myocardial infarction: a meta-analysis. Hristov M, Heussen N, Schober A, Weber C, J Cell Mol Med 2006 10 727 733 10.1111/j.1582-4934.2006.tb00432.x 16989732 (Pubitemid 44874281)
6. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systemic review and meta-analysis of controlled clinical trials. Lipinski MJ, Biondi-Zoccai GG, Abbate A, Khianey R, Sheiban I, Bartunek J, Vanderheyden M, Kim HS, Kang HJ, Strauer BE, Vetrovec GW, J Am Coll Cardiol 2007 50 1761 1767 10.1016/j.jacc.2007.07.041 17964040 (Pubitemid 47600592)
7. Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. Martin-Rendon E, Brunskill SJ, Hyde CJ, Stanworth SJ, Mathur A, Watt SM, Eur Heart J 2008 29 1807 1818 10.1093/eurheartj/ehn220 18523058
8. Stem cell therapy for cardiac repair: benefits and barriers. Joggerst SJ, Hatzopoulos AK, Expert Rev Mol Med 2009 11 20 39 10.1017/S1462399409001124 19586557
9. Cardiac cell repair therapy: a clinical perspective. Gersh BJ, Simari RD, Behfar A, Terzic CM, Terzic A, Mayo Clin Proc 2009 84 876 892 10.4065/84.10.876 19797777
10. Bone marrow cells regenerate infracted myocardium. Mayo Clin Proc, Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, Pickel J, McKay R, Nadal-Ginard B, Bodine DM, Leri A, Anversa P, Nature 2001 410 701 705 10.1038/35070587 11287958 (Pubitemid 32290358)
11. Bone marrow cells adopt the cardiomyogenic fate in vivo. Rota M, Kajstura J, Hosoda T, Bearzi C, Vitale S, Esposito G, Iaffaldano G, Padin-Iruegas ME, Gonzalez A, Rizzi R, Small N, Muraski J, Alvarez R, Chen X, Urbanek K, Bolli R, Houser SR, Leri A, Sussman MA, Anversa P, Proc Natl Acad Sci USA 2007 104 17783 17788 10.1073/pnas.0706406104 17965233 (Pubitemid 350210912)
12. Haematopoietic stem cells adopt mature haemotopoietic fates in ischaemic myocardium. Balsam LB, Wagers AJ, Christensen JL, Kofidis T, Weissman IL, Robbins RC, Nature 2004 428 668 673 10.1038/nature02460 15034594 (Pubitemid 38524811)
13. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Orlic D, Kajstura J, Chimenti S, Limana F, Jakoniuk I, Quaini F, Nadal-Ginard B, Bodine DM, Leri A, Anversa P, Proc Natl Acad Sci USA 2001 98 10344 10349 10.1073/pnas.181177898 11504914 (Pubitemid 32803022)
14. Stem cells for clinical use in cardiovascular medicine. Menasche P, Thromb Haemost 2005 94 697 701 16270619
15. Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction. Korf-Klingebiel M, Kempf T, Sauer T, Brinkmann E, Fischer P, Meyer GP, Ganser A, Drexler H, Wollert KC, Eur Heart J 2008 29 2851 2858 10.1093/eurheartj/ehn456 18953051
16. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Murry CE, Soonpaa MH, Reinecke H, Nakajima H, Nakajima HO, Rubart M, Pasumarthi KB, Virag JI, Bartelmez SH, Poppa V, Bradford G, Dowell JD, Williams DA, Field LJ, Nature 2004 428 664 668 10.1038/nature02446 15034593 (Pubitemid 38524810)
17. Paracrine mechanisms in adult stem cell signaling and therapy. Gnecchi M, Zhang Z, Ni A, Dzau VJ, Circ Res 2008 103 1204 1219 10.1161/CIRCRESAHA.108. 176826 19028920
18. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocytes apoptosis, reduces remodeling and improves cardiac function. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D, Wang J, Homma S, Edwards NM, Itescu S, Nat Med 2001 7 430 436 10.1038/86498 11283669 (Pubitemid 32298545)
19. Systemic delivery of bone marrow-derived mesenchymal stems cells to the infracted myocardium: feasibility, cell migration, and body distribution. Barbash IM, Chouraqui P, Baron J, Feinberg MS, Etzion S, Tessone A, Miller L, Guetta E, Zipori D, Kedes LH, Kloner RA, Leor J, Circulation 2003 108 863 868 10.1161/01.CIR.0000084828.50310.6A 12900340 (Pubitemid 37022130)
20. Cell therapy for the treatment of coronary heart disease: a critical appraisal. Wollert KC, Drexler H, Nat Rev Cardiol 2010 7 204 215 10.1038/nrcardio.2010.1 20177405
21. First experience with remote left ventricular mapping and transendocardial cell injection with a novel integrated magnetic navigation-guided electromechanical mapping system. Perin EC, Silva GV, Fernandes MR, Munger T, Pandey A, Sehra R, Talcott M, Bichard CJ, Creed J, Wong JW, Oliveira EM, Zheng Y, Canales J, Cardoso CO, Patterson MS, Serruys PW, EuroIntervention 2007 3 142 148 19737699
22. Transvenous intramyocardial cellular delivery increases retention in comparison to intracoronary delivery in a porcine model of acute myocardial infarction. George JC, Goldberg J, Joseph M, Abdulhameed N, Crist J, Das H, Pompili VJ, J Interv Cardiol 2008 21 424 431 10.1111/j.1540-8183.2008.00390.x 19012733
23. Myocardial gene transfer by selective pressure-regulated retrofusion of coronary veins: comparison with surgical and percutaneous intramyocardial gene delivery. Raake P, von Degenfeld G, Hinkel R, Vachenauer R, Sandner T, Beller S, Andrees M, Kupatt C, Schuler G, Boekstegers P, J Am Coll Cardiol 2004 44 1124 1129 10.1016/j.jacc.2004.05.074 15337228 (Pubitemid 39165150)
24. Myocardial homing after intrapericardial infusion of bone marrow mononuclear cells. Branco E, Fioretto ET, Cabral R, Palmera CA, Gregores GB, Stopiglia AJ, Maiorka PC, Lemos PA, Campos C, Takimura C, Ramires JA, Miglino MA, Arq Bras Cardiol 2009 93 50 53 10.1590/S0066-782X2009000900021 19851642
25. Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials. Hou D, Youssef EA, Brinton TJ, Zhang P, Rogers P, Price ET, Yeung AC, Johnstone BH, Yock PG, March KL, Circulation 2005 112 9 Suppl 150 156 16159808
26. A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Freyman T, Polin G, Osman H, Crary J, Lu M, Cheng L, Palasis M, Wilensky RL, Eur Heart J 2006 27 1114 1122 10.1093/eurheartj/ehi818 16510464
27. Intracoronary delivery of mesenchymal stem cells at high flow after myocardial infarction improves distal coronary blood flow and decreases mortality in pigs. Llano R, Epstein S, Zhou R, Zhang H, Hamamdzic D, Keane MG, Freyman T, Wilensky RL, Catheter Cardiovasc Interv 2009 73 251 257 10.1002/ccd.21781 19085935
28. Myocardial no-reflow in humans. Crea F, J Am Coll Cardiol 2009 54 281 292 10.1016/j.jacc.2009.03.054 19608025
29. Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction. Perin EC, Silva GV, Assad JA, Vela D, Buja LM, Sousa AL, Litovsky S, Lin J, Vaughn WK, Coulter S, Fernandes MR, Willerson JT, J Mol Cell Cardiol 2008 44 486 495 10.1016/j.yjmcc.2007.09.012 18061611 (Pubitemid 351374698)
30. Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs. Vulliet PR, Greeley M, Halloran SM, MacDonald KA, Kittleson MD, Lancet 2004 363 783 784 10.1016/S0140-6736(04)15695-X 15016490 (Pubitemid 38315169)
31. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomized controlled trial. Janssens S, Dubois C, Bogaert J, Theunissen K, Deroose C, Desmet W, Kalantzi M, Herbots L, Sinnaeve P, Dens J, Maertens J, Rademakers F, Dymarkowski S, Gheysens O, Van Cleemput J, Bormans G, Nuyts J, Belmans A, Mortelmans L, Boogaerts M, Van de Werf F, Lancet 2006 367 113 121 10.1016/S0140-6736(05)67861- 0 16413875 (Pubitemid 43077127)
32. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomized controlled trial. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, Fichtner S, Korte T, Hornig B, Messinger D, Arseniev L, Hertenstein B, Ganser A, Drexler H, Lancet 2004 364 141 148 10.1016/S0140-6736(04)16626-9 15246726 (Pubitemid 38891685)
33. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. Schächinger V, Erbs S, Elsässer A, Haberbosch W, Hambrecht R, Hölschermann H, Yu J, Corti R, Mathey DG, Hamm CW, Süselbeck T, Assmus B, Tonn T, Dimmeler S, Zeiher AM, REPAIR-AMI Investigators, N Engl J Med 2006 355 1210 1221 10.1056/NEJMoa060186 16990384 (Pubitemid 44427445)
34. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Strauer BE, Brehm M, Zeus T, Köstering M, Hernandez A, Sorg RV, Kögler G, Wernet P, Circulation 2002 106 1913 1918 10.1161/01.CIR.0000034046.87607.1C 12370212 (Pubitemid 35176294)
35. Intracoronary infusion of autologous mononuclear bone marrow cells in patients with acute myocardial infarction treated with primary PCI: pilot study of the multicenter HEBE trial. Hirsch A, Nijveldt R, van der Vleuten PA, Tio RA, van der Giessen WJ, Marques KM, Doevendans PA, Waltenberger J, Ten Berg JM, Aengevaeren WR, Biemond BJ, Tijssen JG, van Rossum AC, Piek JJ, Zijlstra F, Catheter Cardiovas Interv 2008 71 273 281 10.1002/ccd.21337 (Pubitemid 351428139)
36. Analysis of myocardial oedema by magnetic resonance imaging early after coronary artery occlusion with or without reperfusion. García-Dorado D, Oliveras J, Gili J, Sanz E, Pérez-Villa F, Barrabés J, Carreras MJ, Solares J, Soler-Soler J, Cardiovasc Res 1993 27 1462 1469 10.1093/cvr/27.8.1462 8297415 (Pubitemid 23265067)
37. Intracoronary administration of bone marrow-derived progenitor cells improve left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy. Dill T, Schächinger V, Rolf A, Möllmann S, Thiele H, Tillmanns H, Assmus B, Dimmeler S, Zeiher AM, Hamm C, Am Heart J 2009 157 541 547 10.1016/j.ahj.2008.11.011 19249426
38. Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction. Huikuri HV, Kervinen K, Niemelä M, Ylitalo K, Säily M, Koistinen P, Savolainen ER, Ukkonen H, Pietilä M, Airaksinen JK, Knuuti J, Mäkikallio TH, FINCELL Investigators, Eur Heart J 2008 29 2723 2732 10.1093/eurheartj/ehn436 18845667
39. Intracoronary infusion of bone marrow-derived selected CD34+ CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicenter Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) trial. Tendera M, Wojakowski W, Ruzyo W, Chojnowska L, Kepka C, Tracz W, Musiaek P, Piwowarska W, Nessler J, Buszman P, Grajek S, Breborowicz P, Majka M, Ratajczak MZ, REGENT Investigators, Eur Heart J 2009 30 1313 1321 10.1093/eurheartj/ehp073 19208649
40. Transcoronary transplantation of progenitor cells after myocardial infarction. Assmus B, Honold J, Schächinger V, Britten MB, Fischer-Rasokat U, Lehmann R, Teupe C, Pistorius K, Martin H, Abolmaali ND, Tonn T, Dimmeler S, Zeiher AM, N Engl J Med 2006 355 1222 1232 10.1056/NEJMoa051779 16990385 (Pubitemid 44427446)
41. Regenerating the heart. Laflamme MA, Murry CE, Nat Biotechnol 2005 23 845 856 10.1038/nbt1117 16003373 (Pubitemid 43093128)
42. The BALANCE Study. Clinical benefit and long-term outcome after intracoronary autologous bone marrow cell transplantation in patients with acute myocardial infarction. Yousef M, Schannwell CM, Köstering M, Zeus T, Brehm M, Strauer BE, J Am Coll Cardiol 2009 53 2262 2269 10.1016/j.jacc.2009.02.051 19520249
43. Bone marrow cells regenerate infarcted myocardium. Orlic D, Kajstura J, Chimenti S, Bodine DM, Leri A, Anversa P, Nature 2001 410 701 705 10.1038/35070587 11287958 (Pubitemid 32290358)
44. Assessment and optimization of cell engraftment after transplantation into the heart. Terrovitis JV, Smith RR, Marban E, Circ Res 2010 106 479 494 10.1161/CIRCRESAHA.109.208991 20167944
45. A placebo controlled dose-ranging, safety study of allogenic mesenchymal stem cells injected by endomyocardial delivery after an acute myocardial infarction. Hashemi SM, Ghods S, Kolodgie FD, Parcham-Azad K, Keane M, Hamamdzic D, Young R, Rippy MK, Virmani R, Litt H, Wilensky RL, Eur Heart J 2008 29 251 259 10.1093/eurheartj/ehm559 18073226
46. Importance of the SDF-1:CXCR4 axis in myocardial repair. Penn MS, Circ Res 2009 104 1133 1135 10.1161/CIRCRESAHA.109.198929 19461103
47. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Askari AT, Unzek S, Popovic ZB, Goldman CK, Forudi F, Kiedrowski M, Rovner A, Ellis SG, Thomas JD, DiCorleto PE, Topol EJ, Penn MS, Lancet 2003 362 697 703 10.1016/S0140-6736(03)14232-8 12957092 (Pubitemid 37101067)
48. Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression. Tang YL, Zhu W, Cheng M, Chen L, Zhang J, Sun T, Kishore R, Phillips MI, Losordo DW, Qin G, Circ Res 2009 104 1209 1216 10.1161/CIRCRESAHA.109.197723 19407239